P. Ponikowski, A. A. Voors, S. D. Anker, H. Bueno, J. G. Cleland et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC), Eur J Heart Fail, 2016.

C. W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. E. Casey et al., ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America, J Am Coll Cardiol, 2016.

P. Rossignol, A. F. Hernandez, S. D. Solomon, and F. Zannad, Heart failure drug treatment, Lancet, vol.2019, pp.1034-1044, 10175.
URL : https://hal.archives-ouvertes.fr/hal-02510811

D. H. Ellison and G. M. Felker, Diuretic Treatment in Heart Failure, N Engl J Med, United States, vol.378, pp.684-685, 2018.

M. Domanski, J. Norman, B. Pitt, M. Haigney, S. Hanlon et al., Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD), J Am Coll Cardiol, vol.42, issue.4, pp.705-713, 2003.

B. Pitt, G. Williams, W. Remme, F. Martinez, J. Lopez-sendon et al., The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study, Cardiovasc Drugs Ther, vol.15, issue.1, pp.79-87, 2001.

K. Duarte, J. M. Monnez, E. Albuisson, B. Pitt, F. Zannad et al., Prognostic Value of Estimated Plasma Volume in Heart Failure, JACC Heart Fail, vol.2015, issue.11, pp.886-93
URL : https://hal.archives-ouvertes.fr/hal-01236515

P. Rossignol, J. Menard, R. Fay, F. Gustafsson, B. Pitt et al., Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy, J Am Coll Cardiol, vol.58, issue.19, pp.1958-66, 2011.

N. Okumura, P. S. Jhund, J. Gong, M. P. Lefkowitz, A. R. Rizkala et al., Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence from the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial, 2016.

A. Lala, S. E. Mcnulty, R. J. Mentz, S. M. Dunlay, J. M. Vader et al., Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF), Circ Heart Fail, vol.8, issue.4, pp.741-749, 2015.

A. A. Voors and J. M. Ter-maaten, Tackling Early Heart Failure Deaths and Readmissions by Estimating Congestion, JACC Heart Fail, vol.2015, issue.11, pp.894-899

J. J. Mcmurray, S. D. Solomon, S. E. Inzucchi, L. Kober, M. N. Kosiborod et al., N Engl J Med, 2019.

Q. Zhang, Y. Saito, N. Naya, K. Imagawa, S. Somekawa et al., The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A, Hypertens Res, issue.6, pp.1251-1257, 2008.

G. Montalescot, B. Pitt, E. Lopez-de-sa, C. W. Hamm, M. Flather et al., Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study, Eur Heart J, Published on behalf of the European Society of Cardiology The Author, vol.35, pp.2295-302, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01738642

P. Rossignol, J. G. Cleland, S. Bhandari, S. Tala, F. Gustafsson et al., Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study, Circulation, vol.2012, issue.2, pp.271-280